Results 241 to 250 of about 2,266,569 (385)
This study identifies platelet‐derived extracellular vesicles as key immunometabolic regulators in COVID‐19. The delivery of tRF‐His‐GTG‐1 to neutrophils activates TLR8mTOR signaling, disrupts lipophagy, and amplifies NET‐mediated inflammation. Importantly, targeting this axis restores neutrophil homeostasis, offering a potential therapeutic strategy ...
Tsai‐Ling Liao +5 more
wiley +1 more source
Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer. [PDF]
Li F, Zha J, Hu M, Zhang W.
europepmc +1 more source
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun +23 more
wiley +1 more source
Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis. [PDF]
Fitzpatrick R +8 more
europepmc +1 more source
Tumour-intrinsic resistance to immune checkpoint blockade
A. Kalbasi, A. Ribas
semanticscholar +1 more source
Researchers have developed a patient‐derived organ‐on‐a‐chip model for pancreatic cancer by integrating cancer cells with supportive stromal and immune cells inside a microfluidic device. This system mimics the tumor microenvironment, enabling personalized testing of chemotherapy and immunotherapy, and offering new insights into how targeting ...
Darbaz Adnan +11 more
wiley +1 more source
Immune Checkpoint Therapy for Thymic Carcinoma. [PDF]
Li J, Mao F, Liu H, Chen J.
europepmc +1 more source
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
Douglas B. Johnson +31 more
semanticscholar +1 more source
IL‐15‐engineered stem cell–NK cell complexes, assembled via bioorthogonal chemistry, enable effective lung cancer immunotherapy. Abstract Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation.
Qian Zhang +15 more
wiley +1 more source
Immune checkpoint blockade in cancer: current insights and future horizons. [PDF]
Saman H +14 more
europepmc +1 more source

